{
    "2020-09-27": [
        [
            {
                "time": "",
                "original_text": "【国信医药】海外第二波疫情来袭，关注检测板块业绩弹性（周观点）",
                "features": {
                    "keywords": [
                        "海外第二波疫情",
                        "检测板块",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：海外第二波疫情来袭 关注检测板块业绩弹性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "海外第二波疫情",
                        "检测板块",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "两家知名药企合作了",
                "features": {
                    "keywords": [
                        "药企",
                        "合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "郭广昌再调仓：复星旅文过冬，复星医药春来",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "复星旅文",
                        "复星医药",
                        "调仓"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "旅游"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "两家知名药企围绕50亿大品种的改良新药开展合作",
                "features": {
                    "keywords": [
                        "药企",
                        "50亿大品种",
                        "改良新药",
                        "合作"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "2020中国大健康产业峰会：重构产业价值 聚焦疫后医疗新机遇",
                "features": {
                    "keywords": [
                        "大健康产业",
                        "峰会",
                        "重构产业价值",
                        "疫后医疗",
                        "新机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】医药领涨大盘，从成长属性再看API投资逻辑",
                "features": {
                    "keywords": [
                        "医药",
                        "领涨大盘",
                        "成长属性",
                        "API投资逻辑"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "API"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}